J2545 HCPCS Level II code: Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
J2545 is the HCPCS code for “Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2545Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
Short description: Pentamidine non-comp unit
HCPCS · United States
Notes for J2545
As CMS prints them, with any note J2545 takes from the headings above it.
Note
- CMS processing note 0127: PUBLICATION 100.2, CHAPTER 15, 50.1.
Medicare details
The indicators CMS publishes with J2545 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Drugs Administered through DME
- Added
- Jan 1, 1992
Where J2545 sits
- 1J codesDrugs administered other than orally
- 2Active code J2545Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2545 mean?
J2545 is the HCPCS code for “Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2545?
CMS lists J2545’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2545
All J codesJ2510Injection, penicillin g procaine, aqueous, up to 600,000 unitsJ2513Injection, pentastarch, 10% solution, 100 mlJ2515Injection, pentobarbital sodium, per 50 mgJ2516Injection, pentamidine isethionate, 1 mgJ2540Injection, penicillin g potassium, up to 600,000 unitsJ2543Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)J2547Injection, peramivir, 1 mgJ2550Injection, promethazine hcl, up to 50 mgJ2560Injection, phenobarbital sodium, up to 120 mgJ2561Injection, phenobarbital sodium (sezaby), 1 mgJ2562Injection, plerixafor, 1 mgJ2590Injection, oxytocin, up to 10 units